Interferon plus dacarbazine in advanced malignant melanoma: a phase I-II study.
Gundersen
S
S
Flokkmann
A
A
D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008545:Melanoma / Q000628:therapy*
D007370:Interferon Type I; D003606:Dacarbazine